Steven P. Weinheimer

Biolog (United States) — United States

Medicine · Health Sciences

21h-index2.4kcitations34works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Herpesvirus Infections and Treatments(17), HIV/AIDS drug development and treatment(14), HIV Research and Treatment(13), Virus-based gene therapy research(9), Cytomegalovirus and herpesvirus research(9)

Publications34 total

Évaluation des profils génotypiques associés à la sensibilité du VIH-1 à l’ibalizumab
Infectious Diseases Now·2021
Efficacy, Pharmacokinetics, and Safety Over 48 Weeks With Ibalizumab-Based Therapy in Treatment-Experienced Adults Infected With HIV-1: A Phase 2a Study
JAIDS Journal of Acquired Immune Deficiency Syndromes·2021· 20 citedOpen Access
1008. Disease Severity Impact on Long-Term Virologic Response to Ibalizumab in Expanded Access Protocol (TMB-311)
Open Forum Infectious Diseases·2020Open Access
1027. Long-Term Efficacy, Safety, and Durability of Ibalizumab-Based Regimens in Subgroup of TMB-202 Participants
Open Forum Infectious Diseases·2020· 5 citedOpen Access
544. Pharmacokinetic Profile of Ibalizumab From a Phase 3 Trial
Open Forum Infectious Diseases·2018· 2 citedOpen Access
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
New England Journal of Medicine·2018· 220 citedOpen Access
Forty-eight-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1
Open Forum Infectious Diseases·2017· 9 citedOpen Access
Primary Efficacy Endpoint and Safety Results of Ibalizumab in a Phase 3 Study of Heavily Treatment-Experienced Patients With Multidrug-Resistant Human Immunodeficiency Virus-1 Infection
Open Forum Infectious Diseases·2016· 1 citedOpen Access
Development of Oseltamivir Phosphonate Congeners as Anti-influenza Agents
Journal of Medicinal Chemistry·2012· 49 citedOpen Access
845 PRECLINICAL CHARACTERISTICS OF ACH-3102: A NOVEL HCV NS5A INHIBITOR WITH IMPROVED POTENCY AGAINST GENOTYPE-1A VIRUS AND VARIANTS RESISTANT TO 1ST GENERATION OF NS5A INHIBITORS
Journal of Hepatology·2012· 18 cited
The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment
Antiviral Research·2011· 27 citedOpen Access
Loss of Asparagine-Linked Glycosylation Sites in Variable Region 5 of Human Immunodeficiency Virus Type 1 Envelope Is Associated with Resistance to CD4 Antibody Ibalizumab
Journal of Virology·2011· 70 citedOpen Access
Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults
Antimicrobial Agents and Chemotherapy·2008· 160 citedOpen Access
Atazanavir Signature I50L Resistance Substitution Accounts for Unique Phenotype of Increased Susceptibility to Other Protease Inhibitors in a Variety of Human Immunodeficiency Virus Type 1 Genetic Backbones
Antimicrobial Agents and Chemotherapy·2005· 36 citedOpen Access
Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine
Antimicrobial Agents and Chemotherapy·2004· 537 citedOpen Access
366 Combination studies involving entecavir and HIV nucleoside reverse transcriptase inhibitors showed no antagonistic effects on HBV or HIV activity in vitro
Journal of Hepatology·2004· 7 cited
The role of viruses in human cancer development and antiviral approaches for intervention.
PubMed·2002· 8 cited
Efficacies of Entecavir against Lamivudine-Resistant Hepatitis B Virus Replication and Recombinant Polymerases In Vitro
Antimicrobial Agents and Chemotherapy·2002· 192 citedOpen Access
Functional Conservations of the Alkaline Nuclease of Herpes Simplex Type 1 and Human Cytomegalovirus
Virology·1998· 20 cited
The human cytomegalovirus UL98 gene encodes the conserved herpesvirus alkaline nuclease.
Journal of General Virology·1997· 32 cited
page 1 of 2Next →

Frequent Co-authors

Donald R. O’Boyle(9), Stanley T. Lewis(8), John T. Stevens(6), Carolyn L. DiIanni(6), Richard J. Colonno(5), Princy Kumar(5), Christian Marsolais(5), Shannon Schrader(4), Gregory Yamanaka(4), P.J. McCann(4), Linda Discotto(3), Gary Richmond(3), Diana Drier(3), L Matusick-Kumar(3), William W. Newcomb(3), Jay C. Brown(3), Claudio Mapelli(3), Jonglin Tsao(3), Pedro Mesquita(3), Daniel J. Tenney(2)